Imagine a
virtual human
not made of flesh and bones, but bits and bytes...
... which thanks to
super computers
... makes medical testing and clinical trials work for
everyone...
ELEM Biotech took part in the ESC Congress 2024
We presented the preliminary findings of the study MyoFit46 with the UCL
Download our poster here 👉📄
ELEM creates populations of virtual humans to predict the outcome of pharmacological and medical device therapeutics.
These models evolve into virtual populations mirroring the diversity and pathologies of society.

Pharmaceutical or Medtech companies, and CROs use our supercomputer-based in-silico trials to test products from discovery to pre-clinical to clinical phases.
ELEM is the future of medicine. Now.
Watch our video to learn more
    Within a supercomputer, many virtual versions of you can explore small changes in your lifestyle and how they affect your health, aging and quality of life.

    Virtual humans: helping you to figure out the very best that you can be.

Read our Case Studies

Clexio
Optimized drug delivery using ELEMs in silico modeling for Clexio’s CLE-500 device to relieve Cluster Headaches
Read case
Cardiac Safety Assessment
Global German pharmaceutical company employs ELEM Virtual Human Trials as pre-clinical Cardiac Safety Assessment
Read case
Bio San Diego, 2024
Bio International Conference, CA, 2024. Find out more about the press conference details
Read more

ABOUT

Company and team

ELEM Biotech is the biomedical simulation spin-off from the Barcelona Supercomputing Center

Get to know us

TECH

Technology and expertise

The most sophisticated and powerful Virtual Humans simulation supercomputing cloud-deployed platform

Learn more

MEDIA

In the media and events

Follow us in the media, conferences, workshops...

Catch up

YOU

Let's talk

Customers, investors, just a curious person...
Or if you want to JOIN US, because we are hiring!
Contact us

Our Partners



Our Sponsors